The global, regional, and national burden of psoriasis in 195 countries and territories, 1990–2017: A systematic analysis from the Global Burden of Disease Study 2017
Journal of the American Academy of Dermatology | May 06, 2020
Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: Results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials
Journal of the European Academy of Dermatology and Venereology | Apr 19, 2020